Look forward to any gleanings from the grapevine in the future. As you say they have finally bitten the bullet and got a decent chunk of funding and I believe the required focus from here. It's been quite a journey to a commercial way of thinking. I have a couple of grapevine sources too and many have looked on PYC with watchful eyes knowing it has the potential that never quite nailed it. From what I understand there is already a change in thinking of a few (pharma & investors) if they have sufficient cash to get them pre-clinical (possible take out in the $200-400m range) which it appears they may. There also seems to be some raised eyebrows at the cancer pilot response and Omomyc response and possible alternatives. Anyway - I wouldn't write off Genetech just yet - one thing I do like about PYC is so far they haven't bowed to the instatiable demand from us HC types for a daily feed of temperature takes from the mice. Solid 6 months ahead with the cash in the bank and most likely a 2-5c valuation at some stage. What happens from there requires a financial milestone IMHO and a big one.
- Forums
- ASX - By Stock
- PYC
- PYC
PYC, page-4
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.005(5.00%) |
Mkt cap ! $466.6M |
Open | High | Low | Value | Volume |
10.0¢ | 10.5¢ | 10.0¢ | $86.04K | 836.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 447169 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 93901 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 377169 | 0.100 |
3 | 712199 | 0.099 |
3 | 160000 | 0.098 |
2 | 105176 | 0.097 |
1 | 100000 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 565628 | 10 |
0.110 | 939436 | 6 |
0.115 | 1308674 | 7 |
0.120 | 570289 | 4 |
0.125 | 366111 | 3 |
Last trade - 11.54am 09/08/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |